Gatifloxacin treatment for chronic prostatitis: A prospective multicenter clinical trial

Journal of Infection and Chemotherapy

Volumn 14, Issue 2, 2008, Pages 137-140

  Kunishima, Yasuharu ^a   Takeyama, Koh ^a   Takahashi, Satoshi ^a   Matsukawa, Masanori ^b   Koroku, Mikio ^c   Tanda, Hitoshi ^c   Tanaka, Toshiaki ^d   Hirose, Takaoki ^d   Iwasawa, Akihiko ^e   Nishimura, Masahiro ^f   Takeda, Kou Ichi ^g   Suzuki, Nobukazu ^g   Horita, Hiroki ^h   Yokoo, Akifumi ⁱ   Tsukamoto, Taiji ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NTT CORPORATION   (Japan)

^c Sanjukai Urological Hospital   (Japan)

^d Hokkaido Social Insurance Hospital   (Japan)

^e Iwasawa Clinic   (Japan)

^f Motomachi Urologic Clinic   (Japan)

^g Teine Urologic Clinic   (Japan)

^h Hokkaido Saiseikai Otaru Hospital   (Japan)

ⁱ Saka Urological Hospital   (Japan)

Author keywords

Chronic prostatitis; Gatifloxacin; Multicenter clinical trial; National Institutes of Health Chronic Prostatitis Symptom Index (NIH CPSI)

Indexed keywords

GATIFLOXACIN;

ADULT; AGED; ARTICLE; CHRONIC PROSTATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG ERUPTION; ENTEROCOCCUS FAECALIS; HEALTH CARE ORGANIZATION; HUMAN; KLEBSIELLA OXYTOCA; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTICENTER STUDY; SCORING SYSTEM; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HOMINIS; STOMACH PAIN; STREPTOCOCCUS AGALACTIAE; SYMPTOMATOLOGY; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

EID: 43049119662     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-008-0593-4     Document Type: Article

References (11)